Provision of Drugs for Post-exposure Prophylaxis of HIV for Medical Students on Overseas Electives
Objectives: To assess the need for, and the most practical way to provide, HIV post-exposure prophylaxis (PEP) for medical students travelling to areas where this is not readily available. Methods: Follow-up questionnaire for all 140 students from Dundee University returning from their medical elect...
Gespeichert in:
Veröffentlicht in: | The Journal of infection 2001-10, Vol.43 (3), p.191-194 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 194 |
---|---|
container_issue | 3 |
container_start_page | 191 |
container_title | The Journal of infection |
container_volume | 43 |
creator | Franklin, G.F. Gray, K. Nathwani, D. |
description | Objectives: To assess the need for, and the most practical way to provide, HIV post-exposure prophylaxis (PEP) for medical students travelling to areas where this is not readily available.
Methods: Follow-up questionnaire for all 140 students from Dundee University returning from their medical elective in 2000, 22 of whom took triple therapy for PEP with them on elective.
Results: 103/140 students (74%) returned questionnaires. 76/103 (74%) were involved in exposure-prone procedures and 38/103 (37%) reported a significant exposure to potentially infective fluids. Six of this group considered PEP but none reported using it. The greatest perceived risk on elective remained road accidents. 87/103 respondents thought a 24-h helpline for health issues on electives would be useful.
Conclusions: A high number of students report significant exposure to potentially infected fluids and this needs to be urgently addressed. There was almost unanimous endorsement of the idea of providing PEP and when it is made easily available prior to travel, students are willing to take it to areas where it is not available. In response to the survey, the investigators are looking at how to increase the current limited supply of PEP (Students may have to pay part of the cost) and the best way to provide a helpline, as it is felt that this could have a broad impact on student safety on electives, not just for issues involving PEP. |
doi_str_mv | 10.1053/jinf.2001.0903 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18299849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016344530190903X</els_id><sourcerecordid>18299849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-7f094ba1eeb4cd6460954261b020cde9e5473e4b0b390d9f63390cdf069eb2093</originalsourceid><addsrcrecordid>eNp10MtP3DAQwGELtYKF9soR5VJu2Y4fycbHikdBogKpj6vlOGMwysZbT7KC_74OuxKnyoc5-LNl_xg75bDkUMmvz2HwSwHAl6BBHrAFr6QoxUqJD2wBvJalUpU8YsdEzwCgpa4P2RHnK92Iqlmw9iHFbaAQhyL64jJNj1T4mIqHSGOJL5tIU8Iio83Ta29fAs3s5vbPG_qBXXC2L36OU4fDmPeG4n6LidBScdWjG8MW6RP76G1P-Hk_T9jv66tfFzfl3f3324tvd6VTwMdy5UGr1nLEVrmuVjXoSomatyDAdaixUiuJqoVWaui0r2WervNQa2xF_tkJO9_du0nx74Q0mnUgh31vB4wTGd4IrRs1w-UOuhSJEnqzSWFt06vhYOaqZq5q5qpmrpoPnO1vnto1du98nzGDL3tgKQfxyQ4u0LtTeXFdZdfsHOYO24DJkAs4uNwx5Vqmi-F_b_gHCsGTdQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18299849</pqid></control><display><type>article</type><title>Provision of Drugs for Post-exposure Prophylaxis of HIV for Medical Students on Overseas Electives</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Franklin, G.F. ; Gray, K. ; Nathwani, D.</creator><creatorcontrib>Franklin, G.F. ; Gray, K. ; Nathwani, D.</creatorcontrib><description>Objectives: To assess the need for, and the most practical way to provide, HIV post-exposure prophylaxis (PEP) for medical students travelling to areas where this is not readily available.
Methods: Follow-up questionnaire for all 140 students from Dundee University returning from their medical elective in 2000, 22 of whom took triple therapy for PEP with them on elective.
Results: 103/140 students (74%) returned questionnaires. 76/103 (74%) were involved in exposure-prone procedures and 38/103 (37%) reported a significant exposure to potentially infective fluids. Six of this group considered PEP but none reported using it. The greatest perceived risk on elective remained road accidents. 87/103 respondents thought a 24-h helpline for health issues on electives would be useful.
Conclusions: A high number of students report significant exposure to potentially infected fluids and this needs to be urgently addressed. There was almost unanimous endorsement of the idea of providing PEP and when it is made easily available prior to travel, students are willing to take it to areas where it is not available. In response to the survey, the investigators are looking at how to increase the current limited supply of PEP (Students may have to pay part of the cost) and the best way to provide a helpline, as it is felt that this could have a broad impact on student safety on electives, not just for issues involving PEP.</description><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1053/jinf.2001.0903</identifier><identifier>PMID: 11798258</identifier><identifier>CODEN: JINFD2</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Accidents ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Follow-Up Studies ; Health Promotion ; HIV Infections - prevention & control ; Human immunodeficiency virus 1 ; Humans ; Medical sciences ; Occupational Exposure ; Pharmacology. Drug treatments ; Risk Factors ; Students, Medical ; Surveys and Questionnaires ; Travel ; Universities</subject><ispartof>The Journal of infection, 2001-10, Vol.43 (3), p.191-194</ispartof><rights>2001 The British Infection Society</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2001 The British Infection Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-7f094ba1eeb4cd6460954261b020cde9e5473e4b0b390d9f63390cdf069eb2093</citedby><cites>FETCH-LOGICAL-c401t-7f094ba1eeb4cd6460954261b020cde9e5473e4b0b390d9f63390cdf069eb2093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/jinf.2001.0903$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14141195$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11798258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Franklin, G.F.</creatorcontrib><creatorcontrib>Gray, K.</creatorcontrib><creatorcontrib>Nathwani, D.</creatorcontrib><title>Provision of Drugs for Post-exposure Prophylaxis of HIV for Medical Students on Overseas Electives</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><description>Objectives: To assess the need for, and the most practical way to provide, HIV post-exposure prophylaxis (PEP) for medical students travelling to areas where this is not readily available.
Methods: Follow-up questionnaire for all 140 students from Dundee University returning from their medical elective in 2000, 22 of whom took triple therapy for PEP with them on elective.
Results: 103/140 students (74%) returned questionnaires. 76/103 (74%) were involved in exposure-prone procedures and 38/103 (37%) reported a significant exposure to potentially infective fluids. Six of this group considered PEP but none reported using it. The greatest perceived risk on elective remained road accidents. 87/103 respondents thought a 24-h helpline for health issues on electives would be useful.
Conclusions: A high number of students report significant exposure to potentially infected fluids and this needs to be urgently addressed. There was almost unanimous endorsement of the idea of providing PEP and when it is made easily available prior to travel, students are willing to take it to areas where it is not available. In response to the survey, the investigators are looking at how to increase the current limited supply of PEP (Students may have to pay part of the cost) and the best way to provide a helpline, as it is felt that this could have a broad impact on student safety on electives, not just for issues involving PEP.</description><subject>Accidents</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Follow-Up Studies</subject><subject>Health Promotion</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Occupational Exposure</subject><subject>Pharmacology. Drug treatments</subject><subject>Risk Factors</subject><subject>Students, Medical</subject><subject>Surveys and Questionnaires</subject><subject>Travel</subject><subject>Universities</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtP3DAQwGELtYKF9soR5VJu2Y4fycbHikdBogKpj6vlOGMwysZbT7KC_74OuxKnyoc5-LNl_xg75bDkUMmvz2HwSwHAl6BBHrAFr6QoxUqJD2wBvJalUpU8YsdEzwCgpa4P2RHnK92Iqlmw9iHFbaAQhyL64jJNj1T4mIqHSGOJL5tIU8Iio83Ta29fAs3s5vbPG_qBXXC2L36OU4fDmPeG4n6LidBScdWjG8MW6RP76G1P-Hk_T9jv66tfFzfl3f3324tvd6VTwMdy5UGr1nLEVrmuVjXoSomatyDAdaixUiuJqoVWaui0r2WervNQa2xF_tkJO9_du0nx74Q0mnUgh31vB4wTGd4IrRs1w-UOuhSJEnqzSWFt06vhYOaqZq5q5qpmrpoPnO1vnto1du98nzGDL3tgKQfxyQ4u0LtTeXFdZdfsHOYO24DJkAs4uNwx5Vqmi-F_b_gHCsGTdQ</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Franklin, G.F.</creator><creator>Gray, K.</creator><creator>Nathwani, D.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20011001</creationdate><title>Provision of Drugs for Post-exposure Prophylaxis of HIV for Medical Students on Overseas Electives</title><author>Franklin, G.F. ; Gray, K. ; Nathwani, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-7f094ba1eeb4cd6460954261b020cde9e5473e4b0b390d9f63390cdf069eb2093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Accidents</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Follow-Up Studies</topic><topic>Health Promotion</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Occupational Exposure</topic><topic>Pharmacology. Drug treatments</topic><topic>Risk Factors</topic><topic>Students, Medical</topic><topic>Surveys and Questionnaires</topic><topic>Travel</topic><topic>Universities</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franklin, G.F.</creatorcontrib><creatorcontrib>Gray, K.</creatorcontrib><creatorcontrib>Nathwani, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franklin, G.F.</au><au>Gray, K.</au><au>Nathwani, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Provision of Drugs for Post-exposure Prophylaxis of HIV for Medical Students on Overseas Electives</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2001-10-01</date><risdate>2001</risdate><volume>43</volume><issue>3</issue><spage>191</spage><epage>194</epage><pages>191-194</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><coden>JINFD2</coden><abstract>Objectives: To assess the need for, and the most practical way to provide, HIV post-exposure prophylaxis (PEP) for medical students travelling to areas where this is not readily available.
Methods: Follow-up questionnaire for all 140 students from Dundee University returning from their medical elective in 2000, 22 of whom took triple therapy for PEP with them on elective.
Results: 103/140 students (74%) returned questionnaires. 76/103 (74%) were involved in exposure-prone procedures and 38/103 (37%) reported a significant exposure to potentially infective fluids. Six of this group considered PEP but none reported using it. The greatest perceived risk on elective remained road accidents. 87/103 respondents thought a 24-h helpline for health issues on electives would be useful.
Conclusions: A high number of students report significant exposure to potentially infected fluids and this needs to be urgently addressed. There was almost unanimous endorsement of the idea of providing PEP and when it is made easily available prior to travel, students are willing to take it to areas where it is not available. In response to the survey, the investigators are looking at how to increase the current limited supply of PEP (Students may have to pay part of the cost) and the best way to provide a helpline, as it is felt that this could have a broad impact on student safety on electives, not just for issues involving PEP.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>11798258</pmid><doi>10.1053/jinf.2001.0903</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-4453 |
ispartof | The Journal of infection, 2001-10, Vol.43 (3), p.191-194 |
issn | 0163-4453 1532-2742 |
language | eng |
recordid | cdi_proquest_miscellaneous_18299849 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Accidents Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Follow-Up Studies Health Promotion HIV Infections - prevention & control Human immunodeficiency virus 1 Humans Medical sciences Occupational Exposure Pharmacology. Drug treatments Risk Factors Students, Medical Surveys and Questionnaires Travel Universities |
title | Provision of Drugs for Post-exposure Prophylaxis of HIV for Medical Students on Overseas Electives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T21%3A50%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Provision%20of%20Drugs%20for%20Post-exposure%20Prophylaxis%20of%20HIV%20for%20Medical%20Students%20on%20Overseas%20Electives&rft.jtitle=The%20Journal%20of%20infection&rft.au=Franklin,%20G.F.&rft.date=2001-10-01&rft.volume=43&rft.issue=3&rft.spage=191&rft.epage=194&rft.pages=191-194&rft.issn=0163-4453&rft.eissn=1532-2742&rft.coden=JINFD2&rft_id=info:doi/10.1053/jinf.2001.0903&rft_dat=%3Cproquest_cross%3E18299849%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18299849&rft_id=info:pmid/11798258&rft_els_id=S016344530190903X&rfr_iscdi=true |